Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,262 Colorectal Cancer
clinical trials

Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Butternut
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Gulfport Memorial Hospital
mi
from
Gulfport, MS
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Straub Clinic And Hospital
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeastern Medical Oncology Center-Jacksonville
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Cancer Care-Kenosha South
mi
from
Kenosha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare - Kewanee Clinic
mi
from
Kewanee, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
McFarland Clinic PC-Marshalltown
mi
from
Marshalltown, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute - Meridian
mi
from
Meridian, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Cancer Care-Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Meharry Medical College
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Medical Center Jefferson
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
NYP Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Newberg Medical Center
mi
from
Newberg, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Vince Lombardi Cancer Clinic - Oshkosh
mi
from
Oshkosh, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente - Panorama City
mi
from
Panorama City, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Saint Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare - Princeton
mi
from
Princeton, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-San Diego Zion
mi
from
San Diego, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Santa Teresa-San Jose
mi
from
San Jose, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente San Leandro
mi
from
San Leandro, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
UW Cancer Center at ProHealth Care
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Winchester Hospital
mi
from
Winchester, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of TRK-950 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Clinical Trial
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Clinical Trial
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Dana-Farber Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Multicenter Phase II Study of Transanal TME (taTME)
Status: Enrolling
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Multicenter Phase II Study of Transanal TME (taTME)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Beth Israel
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Multicenter Phase II Study of Transanal TME (taTME)
Status: Enrolling
Updated: 12/31/1969
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Integration of Cancer Health Activities Into African American Churches
Status: Enrolling
Updated: 6/5/2017
University of Maryland School of Public Health
mi
from
College Park, MD
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Implementing Preemptive Pharmacogenomic Testing for Colorectal Cancer Patients in a Community Oncology Clinic
Status: Enrolling
Updated: 12/31/1969
Essentia Health
mi
from
Duluth, MN
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
Status: Enrolling
Updated: 12/31/1969
John Peter Smith Health Network
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Chicago Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Vanderbilt University School of Medicine
mi
from
Nashville, TN
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kaiser Permanente - Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kaiser Permanente-San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Northwest Georgia Oncology Centers, PC
mi
from
Marietta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Spartanburg Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Clinic Cancer & Hematology - Chub O'Reilly Cancer Center
mi
from
Springfield, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
The Angeles Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Providence Oncology & Hematology Care Eastside
mi
from
Portland, OR
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Panitumumab in Combination With Trametinib in Cetuximab-Refractory Stage IV Colorectal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Study to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Study to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Study to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)
Status: Enrolling, Phase I
Updated: 3/19/2018
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)
Status: Enrolling, Phase I
Updated: 3/19/2018
HonorHealth Research Institute
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Longitudinal Performance of Epi proColon
Status: Enrolling
Updated: 2/13/2018
Beaumont Health System
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
Status: Enrolling, Phase I, II
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
PEN-866 in Patients With Advanced Solid Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*1101 Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Charleston, SC
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Orange, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California
mi
from
San Francisco, CA
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
UF Health Shands Cancer Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
Colonic Polyps Clinical Trial
Use of Accessory Device AmplifEYE During Average Risk Screening Colonoscopy to Increase Adenoma Detection Rate
Status: Enrolling
Updated: 8/22/2017
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Oncology Hematology West, PC dba Nebraska Cancer Specialists
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Harrison Medical Center
mi
from
Bremerton, WA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Pacific Gynecology Specialists
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Alaska Women's Cancer Care
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth Saint Joseph Medical Center
mi
from
Bellingham, WA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Strecker Cancer Center-Belpre
mi
from
Belpre, OH
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Charles Health System
mi
from
Bend, OR
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Alta Bates Summit Medical Center-Herrick Campus
mi
from
Berkeley, CA
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Vincent Healthcare
mi
from
Billings, MT
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Boulder
mi
from
Boulder, CO
Click here to add this to my saved trials
1 … 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 83